Prospective cohort study to investigate 2-year visual outcome of a treat and extend protocol involving administration of bevacizumab or ranibizumab
Latest Information Update: 12 Dec 2015
At a glance
- Drugs Bevacizumab (Primary) ; Ranibizumab (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
Most Recent Events
- 12 Dec 2015 New trial record